Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. KTTAW.NASDAQ

Pasithea Therapeutics Corp. Warrant (KTTAW NASDAQ) stock market data APIs

$0.0163 0(0%) as of July 26, 2024
Price chart is built with Anychart

Pasithea Therapeutics Corp., a biotechnology company, engages in discovery, research, and development of treatments for central nervous system disorders, RASopathies, and other diseases. Its lead product candidate PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor for use in the treatment of a range of RASopathies, including neurofibromatosis type 1 oncology indications. The company intends to develop PAS-003, to treat amyotrophic lateral sclerosis; and PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.

Pasithea Therapeutics Corp. Warrant Financial Data Overview

0.0163
0.0163
-
0.0163
0.0163
0.0003-0.121
0
0
487 K
0.754
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'KTTAW',
Type: 'Common Stock',
Name: 'Pasithea Therapeutics Corp. Warrant',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG01231TZF3',
ISIN: NULL,
CUSIP: NULL,
CIK: '1841330',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-09-15',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Warrant',
IsDelisted: false,
}

Pasithea Therapeutics Corp. Warrant Fundamental Data is available in our Financial Data APIs

  • Net Revenue 487 K
  • EBITDA -16 158 591
  • Earnings Per Share
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Pasithea Therapeutics Corp. Warrant Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get Pasithea Therapeutics Corp. Warrant End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Pasithea Therapeutics Corp. Warrant latest news via APIs

Pasithea Therapeutics Announces Adjournment of 2023 Annual Meeting of Stockholders

SOUTH SAN FRANCISCO, Calif. and MIAMI, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (“Pasithea” or the “Company”) (NASDAQ: KTTA), today announced that its annual meeting of ...
  • AGM
  • ANNUAL GENERAL MEETING
  • ANNUAL MEETINGS & SHAREHOLDER RIGHTS
  • BIOTECHNOLOGY
  • KTTA
  • NASDAQ
  • NASDAQ:KTTA
  • PASITHEA
  • PASITHEA THERAPEUTICS

Pasithea Therapeutics Announces Outcome of Pre-IND Meeting with FDA for PAS-004 Clinical Development

-- Company on track to submit PAS-004 IND application in current quarter -- -- Pasithea plans to begin PAS-004 Phase 1 dose escalation trial in advanced solid tumor patients harboring RAS, RAF and ...
  • ADVANCED SOLID TUMORS
  • BIOTECH
  • CLINICAL STUDY
  • CLINICAL TRIAL
  • DOSE ESCALATION
  • FDA
  • MANAGEMENT STATEMENTS
  • NASDAQ
  • NASDAQ:KTTA
  • NF1
  • PAS-004
  • PASITHEA
  • PRE-IND MEETING
  • RAF MUTATIONS
  • RAS MUTATIONS
Do you have any questions?
support@eodhistoricaldata.com